Across CCLE and GDSC cell-line panels, response to Selumetinib is significantly associated with the protein-level pathway activity of multiple pathways, with LUNG_NSCLC_LUAD cell lines showing a particularly strong set of associations.
The most reproducible Selumetinib response-associated pathways across cancer lineages are Regulation of cellular extravasation, Phosphatidylethanolamine biosynthetic process, and Aspartate transmembrane transport, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Selumetinib response versus Regulation of cellular extravasation protein-level pathway activity in LUNG_NSCLC_LUAD (Pearson r = -0.34).